Genomics and Precision Medicine - Health Technology Insights - Page 2

Scemblix Gets Positive CHMP Opinion for New CML Treatment

October 17, 2025

Tempus Partners with Whitehawk for Biomarker Oncology Research

October 16, 2025

MilliporeSigma to Acquire JSR’s Chromatography Business

October 15, 2025

Precision BioSciences to Present PBGENE-HBV at AASLD 2025

October 14, 2025

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

October 14, 2025

Inovalon Partners with DoseMe for Precision Dosing in Pharmacy

October 14, 2025

WellTheory Raises $14Million to Build the Category Leader in Autoimmune Care

October 14, 2025

FDA Approves Tecentriq with Lurbinectedin for Lung Cancer

FDA Approves Tecentriq with Lurbinectedin for Lung Cancer

October 3, 2025

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

October 2, 2025

Hologic Gets FDA Clearance for Automated Gastroenteritis Tests

October 2, 2025

AAVantgarde Gains FDA Orphan Status for Stargardt Drug

October 2, 2025

GSK and IQVIA Launch Local Vaccine Data for Public Health

October 1, 2025

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup 26 November 2025

FluidAI Medical Announces an Acquisition Deal With Emmetros Limited

Healgen Highlights Rapid Check Test for COVID-19 and Flu Season

Alleva Earns ONC Certification, SOC 2, and HIPAA Compliance

Tangram Therapeutics Files CTA for TGM-312 Phase 1/2 Study

Tangram Therapeutics Files CTA for TGM-312 Phase 1/2 Study

Herantis Pharma Announces Successful Completion of Six-Month Glp Toxicology Study of Her-096

Herantis Pharma Announces Successful Completion of Six-Month Glp Toxicology Study of Her-096